Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for Mansonella ozzardi mansonelliasis
ACTRN12609000005257Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ivermectin in Mansonelliasis, sponsored by Universidade de São Paulo. Primary endpoint: Microfilaremia clearance. Started Mar 2009; status: completed.
02
Drugs
ivermectin
03
Conditions
Mansonelliasis
Beyond the preview
Go deeper on ACTRN12609000005257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000005257.